All Posts

As a reminder, we are biopharma investors just like you. All of our Elite and Amp portfolios show percent holdings of real money accounts of our co-founder, Manny Vacchiano, JD, PhD. Thus, we are always looking to improve their performance and identify new strategies, including those that are more effective in this current down cycle for biopharma stocks.

As a reminder, we are biopharma investors just like you. All of our Elite and Amp portfolios show percent holdings of real money accounts of our co-founder, Manny Vacchiano, JD, PhD. Thus, we are always looking to improve their performance and identify new strategies, including those that are more effective in this current down cycle for biopharma stocks.

What is a Big-Mover™ event? Big-Mover™ events are upcoming high-impact biopharma catalyst events, usually clinical trial read-outs, that are expected to move a stock by at least 20% up or down. Big Mover™ events are typically a type of event with the highest chance of moving a stock (e.g. Phase 2, Phase 3, and PDUFA read-outs) given the importance of the clinical asset to the sponsor company. We call clinical events that appear likely to be Big Mover events Suspected Big Move

What is a Big-Mover™ event? Big-Mover™ events are upcoming high-impact biopharma catalyst events, usually clinical trial read-outs, that are expected to move a stock by at least 20% up or down. Big Mover™ events are typically a type of event with the highest chance of moving a stock (e.g. Phase 2, Phase 3, and PDUFA read-outs) given the importance of the clinical asset to the sponsor company. We call clinical events that appear likely to be Big Mover events Suspected Big Move

Access our free PDUFA Report! Calendar of PDUFA events this month. Use this info  To update your holdings before an approval To find bullish or bearish trades before and/or across event Read our PDUFA FAQs to learn more   Want even more info to help you find & analyze PDUFA events for future months? Sign up for ELITE (40% off)  limited time offer: Full PDUFA Calendar Deeper data like prior adcoms, CRLs, and more.. Also see which are the biggest stock moving PDUFAs w/ Big Move

Access our free Big-Mover Report Detailed info on biggest clinical readouts of this quarter Use this info:  To update your holdings before a readout To ID bullish or bearish trades before and/or thru readout Read our Big-Mover FAQs  to learn more   Want even more info to help you find & analyze this quarter's biggest movers, and big movers for future quarters? Sign up for ELITE (40% off)  limited time offer: Suspected movers for future quarters Implied volatility, short inter

Our free Big-Mover Report : Listing of 10 of the biggest clinical readouts this quarter Use this info: To update your holdings before a readout To ID bullish or bearish trades before and/or thru readout Want more free clinical readouts this quarter? Click below: https://www.offers.bpiq.com/big-mover-lp Want even more info to help you find & analyze this quarters biggest movers, and big movers for future quarters? Sign up for ELITE (40% off) limited time offer: Suspected mov

Repeating and expanding a bit on a post I just made in our discord chat here: One other comment re: $SRPT, I was looking at possible magnitude up and down on their upcoming big mover readout at end of year. On the one hand, they are already a $10B company so how much higher can they go? Well they have around $1B of annual revenue now, so they are trading at around 10x current revenue, which is not crazy. And if they get approval for all age groups, their addressable market fo

Valuable insights into ALDX

We have gone through the Q2 2023 financial reports to analysis each companies product revenue to see: Q2 '23 revenue Q2 '22 revenue Q2 '23 / Q2 '22 Market cap multiple Approved products Already an Elite member? See the deeper article here! Q1 '23 vs. Q2 '23 revenue comparison Number of hedge funds that hold that company in Q2 '23 This article is NOT legal, investment or tax advice. Please do your own diligence before making any investments. Article history: 8/17/23 first pos